- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02305771
Contributions From the Analysis of Graphs for Identification of Neural Cliques (BRAINGRAPH)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Electroencephalography (EEG) with very High spatial Resolution (HR) (EEG-HR, 256 electrodes) allows for a better understanding of the global and local activity of the cerebral neocortex.
In 2012, following publications by Claude Berrou and Vincent Gripon's Internet, introducing new principles of coding information based on graphical representations in connectionist networks, we approached this team to test biological plausibility of this theory in vivo with EEG.
The central concept is the mental information, defined as all elements of knowledge acquired by the long-term memory on which the reason can build to try to respond to new problems. According to this new theory, these elements of knowledge called qualia or features should be connected within cliques networks. However, we currently do not have graphs comparing methods to measure a good index of both spatial and topological similarity between graphs with high resolution electroencephalography.
For this new study, we propose to combine the strengths of several existing methods of graph comparison which, on top of this, will be especially adapted to the specific context of the analysis of the graphs in the cerebral cortex.
The skills used are diverse: information theory, mathematics, graph theory, computer science, neuropsychology, signal processing and neurology.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Rennes, France, 35033
- Rennes University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years and older
- Right-handed ;
- French native speaker
- Having given written informed consent
Exclusion Criteria:
- Presence of any psychiatric, neuropsychological and developmental disorder
- Any uncorrected visual impairment
- Any trouble or delay in learning to read / speak french
- Fully bilingual or multilingual
- Medication, treatment and / or substances that may alter or modify brain functions
- Pregnancy, breast feeding
- Persons under major legal protection and/or deprived of liberty
MRI-related criterions
- Cardiac pacemaker or implanted defibrillator
- Iron-magnetic surgical clips
- Cochlear implant
- Intra-ocular or brain foreign bodies
- Less than 4 weeks-old stents, less than 6 weeks-old osteosynthesis materials
- Claustrophobia
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Healthy volunteers
20 healthy volunteers will undergo an inclusion visit in order to check inclusion and non inclusion criteria. Then will be performed:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Three main criteria are to be considered to validate the tool for measuring the similarity between the graphs obtained
Time Frame: 2 years
|
Despite the intra-individual variability, the same object or the same sound repeated several times should generate the most similar connectivity graphs Despite the inter-individual variability, analysis of connectivity graphs must also report high similarity indices between individuals on the same stimuli or stimuli sharing the same semantic properties even if subjects are different. At the stage of conceptual analysis of stimuli, or from 175 ms after the presentation of the image or sound, the analysis of connectivity graphs should reveal strong similarity indices for several different images of the same object (independence to the visual representation); for picture and sound representing the same object (independence to the sensory modality) or two objects belonging to the same semantic category (conceptual similarity, eg: orange, lemon). Indeed, these objects share common characteristics / semantic dimensions (eg mobile vs. stationary or living vs. non-living etc.). |
2 years
|
Estimate the plausibility of the results obtained with our method directly from the graphs
Time Frame: 2 years
|
The density (ie: the ratio between the number of links in a given graph on the total possible number of links), the diameter (ie: the longest path in a graph), the average degree (ie: the average number of links connected to each node), the clustering (ie: the density of connections to a group of nodes with the rest of the network) and other parameters will be compared in terms of standard values available in the literature but also with tools that help to calculate the semantic distance between words such as WordNet and many others.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Judgement of the quality of the measurement on simulated data in the laboratory test our method for measuring the similarity between the graphs
Time Frame: 2 years
|
A computer model of neural network populations in which the experimenter knows in advance where the sources are allows him to test the reliability of his methods while reconstructing graphs and judging their similarity.
[8] Finally, the quality of the results about the identification of neural cliques (or complete graphs) could be compared to the artificial neural network model we develop elsewhere [1, 9 and 10].
This model indicates that the distribution of neural cliques (in response to density and efficiency problems) follows a simple principle that we should find in the brain.
For example, it is reasonable to think there are many cliques (or complete graphs) at the scale of a small brain region while those cliques are rare when considering spatially distant sources.
It is an organization called "small-worlds" and which is classical for the neural networks in the cerebral cortex
|
2 years
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014-A01461-46
- 35RC14_9849_BRAINGRAPH (Other Identifier: Rennes University Hospital)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Neuroelectrics CorporationRecruitingEpilepsy | Seizures | Refractory Epilepsy | Epilepsy, Tonic-Clonic | Epilepsy in Children | Seizures, Focal | Focal SeizureSpain, United States, France, Belgium
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
University Hospital, LilleUnknownFocal Epilepsy | Epilepsy IntractableFrance
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsRecruitingEpilepsy, Drug ResistantChina
Clinical Trials on Electroencephalography
-
Centre Hospitalier Universitaire de BesanconTerminated
-
Daegu Catholic University Medical CenterCompletedAttention Deficit Hyperactivity Disorder | Psychiatric Diagnosis | Diagnosis, PsychiatricKorea, Republic of
-
Rennes University HospitalCompleted
-
University Hospital, CaenCentre Hospitalier Universitaire de BesanconNot yet recruitingNeurodevelopmental Changes (Childhood, Ageing)
-
Assistance Publique Hopitaux De MarseilleRecruiting
-
Parc de Salut MarAelis Farma; StarlabRecruiting
-
Poitiers University HospitalUnknownRespiratory Failure | Weaning Failure | Respiration Disorder | Respiratory Compensation | Respiratory Center DysfunctionFrance
-
Ulrich MehnertNCCR (National Center of Competence in Resaerch, Switzerland)CompletedHealthy | Neurogenic Bladder Dysfunction Nos | Nonneurogenic Neurogenic Bladder DysfunctionSwitzerland
-
University of Texas at AustinNot yet recruitingEpilepsy | EEG With Abnormally Slow Frequencies | EEG; Paroxysms, Occipital, Epilepsy of Childhood | EEG With Periodic Abnormalities | EEG; Spikes, Centrotemporal, Epilepsy of ChildhoodUnited States
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruiting